Converting 40 Units to mg in Tirzepatide: What the Numbers Actually Mean

40 units of tirzepatide equals exactly 5 mg, based on the Mounjaro KwikPen's fixed concentration of 1 mg per 8 units.
The Mounjaro 5 mg pen is the second strength in the licensed UK schedule; treatment begins at 2.5 mg (20 units) to allow your body to adjust.
Unit-to-mg conversions for tirzepatide are fixed and consistent across all Mounjaro pen strengths, the ratio does not change between doses.
A prescriber determines which dose is right for you; the conversion is clinical context, not a guide to self-titrating.

Forty units of tirzepatide is equivalent to 5 mg — the second dose strength in the Mounjaro licensed schedule. That figure comes directly from the medicine's concentration: each Mounjaro KwikPen delivers 1 mg per 8 units of solution, so 40 units multiplies out to exactly 5 mg. If you've seen the question phrased differently elsewhere, the answer is the same. Tirzepatide is a prescription-only medicine and the dose you take is decided by a GPhC-registered prescriber after a clinical assessment — knowing the maths helps you understand your treatment, but it doesn't change that process.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The maths behind the 40-units-to-5-mg conversion, and what it means for your treatment

Where the 5 mg figure comes from

The Mounjaro KwikPen is engineered to deliver tirzepatide at a fixed concentration of 0.5 mg per 0.1 ml of solution. Because insulin syringes (and the mental shorthand carried over from insulin dosing) often express volumes in units, some patients and carers naturally ask what that concentration looks like expressed differently. The answer is 8 units per 1 mg, which means 40 units equals 5 mg, full stop. This isn't an approximation, it's the geometry of the pen. The general tirzepatide mg-to-units reference walks through the same relationship across every licensed UK strength if you want to check other doses.

It's worth being clear about something the BNF entry for tirzepatide underlines: Mounjaro is not dosed by drawing up liquid from a vial. The KwikPen is pre-filled and pre-set. You do not measure 40 units with a syringe; the pen delivers its fixed dose when you press the button. The unit conversion is useful intellectual context (it explains a number you may have read online or heard from a previous healthcare provider) but it doesn't involve any action on your part.

One practical checking habit: before each injection, glance at the label on your pen to confirm the mg strength printed matches what your prescriber has indicated for this stage of your treatment. It takes under a minute and removes any ambiguity between, say, a 5 mg and a 7.5 mg pen if you have more than one in the fridge.

How 5 mg sits in the Mounjaro licensed schedule

The UK Mounjaro schedule (as set out in the Summary of Product Characteristics published on the electronic Medicines Compendium) begins at 2.5 mg (that's 20 units, if you're following the conversion). The 2.5 mg starting dose is specifically a tolerability measure; it gives the gastrointestinal system time to adapt to a dual GIP and GLP-1 receptor agonist before the therapeutic work begins in earnest. After approximately four weeks, a prescriber typically titrates the patient to 5 mg. That's the 40-unit equivalent this page covers. From 5 mg, the schedule continues upward at roughly four-week intervals through 7.5, 10, 12.5, and the highest licensed strength of 15 mg, each step subject to clinical review.

For context on what the Mounjaro 5 mg pen involves in practice, the move from the starter strength to 5 mg is where many patients notice the appetite-reduction effect becoming more noticeable. That isn't guaranteed (individual responses vary) but it's consistent with tirzepatide's trial data: SURMOUNT-1, published in the New England Journal of Medicine, recorded average body-weight reductions increasing with dose over 72 weeks, and 5 mg represents the early therapeutic range rather than the ceiling. The 5 mg to units conversion page covers the same dose from the opposite direction if that framing is clearer.

Why the unit framing appears and when it matters

Insulin is dosed in international units, and anyone who has managed type 2 diabetes before starting tirzepatide may instinctively translate their new medicine into the same language. That's understandable. Tirzepatide is also licensed for type 2 diabetes in the UK, which means some patients arrive having spoken to healthcare providers in a diabetes context where unit language is the norm. Others encounter the figure in a conversion table, a pharmacy note, or a peer forum and want to know whether 40 units lines up with what they've been prescribed in milligrams. In all of these cases, the answer is the same: 40 units is 5 mg, expressed in a different but mathematically consistent way.

The distinction that genuinely matters is between understanding a number and acting on it. Knowing that 40 units equals 5 mg tells you what the label means. It does not indicate that 40 units is the dose you should be taking, or that you should move to it, or that you should adjust your current pen. Those decisions belong with your prescriber. Mounjaro as a treatment is a prescription-only medicine precisely because the right dose, and the right moment to change it, requires clinical judgement about your individual history and response. If you have questions about where you are in your titration schedule, the right place to take them is to the clinician managing your care.

The route through a legitimate prescriber

Patients occasionally ask about unit conversions because they're trying to reconcile information from different sources: a previous provider who used unit language, a printed leaflet that quotes milligrams, a friend whose dose sounds numerically different from their own. Getting that reconciliation right is sensible. It's also a good prompt to make sure your treatment is being clinically reviewed regularly rather than just repeated automatically.

If you're exploring treatment options or considering tirzepatide for the first time, the consultation page is the starting point, a prescriber assesses your suitability before any prescription is issued. For existing patients, dose questions belong in an aftercare conversation rather than a conversion table. Understanding how the starter dose maps to units or working through what 5 mg looks like expressed as units can be genuinely helpful background, but background is all it is. The clinical picture is what drives the prescription. If you'd like to understand the broader cost context for private tirzepatide treatment, Mounjaro pricing in the UK sets out what to expect without any surprises. And if you have questions about weight-loss treatment more generally, our team is available seven days a week. Speak to our prescribers, they're the right people to answer anything the conversion table can't.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions